157 related articles for article (PubMed ID: 27354269)
1. Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia.
Trinquand A; Dos Santos NR; Tran Quang C; Rocchetti F; Zaniboni B; Belhocine M; Da Costa de Jesus C; Lhermitte L; Tesio M; Dussiot M; Cosset FL; Verhoeyen E; Pflumio F; Ifrah N; Dombret H; Spicuglia S; Chatenoud L; Gross DA; Hermine O; Macintyre E; Ghysdael J; Asnafi V
Cancer Discov; 2016 Sep; 6(9):972-85. PubMed ID: 27354269
[TBL] [Abstract][Full Text] [Related]
2. Activating TCR Signaling to Thwart T-ALL.
Lemonnier F; Mak TW
Cancer Discov; 2016 Sep; 6(9):946-8. PubMed ID: 27587465
[TBL] [Abstract][Full Text] [Related]
3. Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia.
Ávila Ávila A; Nuantang K; Oliveira ML; Druillennec S; Zaniboni B; Lengliné E; Asnafi V; Ghysdael J; Tran Quang C
Blood; 2024 May; 143(21):2166-2177. PubMed ID: 38437728
[TBL] [Abstract][Full Text] [Related]
4. Effect of accessory cells on stimulation of murine T-cell leukemia with antibodies to the CD3/T cell antigen receptor complex.
Suto R; Udono H; Yamamoto A; Shiku H; Nakayama E
Jpn J Cancer Res; 1993 Apr; 84(4):438-44. PubMed ID: 8514611
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by anti-CD3 epsilon F(ab')2 in antigen receptor transgenic murine T cells activated by specific peptide.
Yu XZ; Zhu L; Davis JE; Tso JY; Hansen JA; Anasetti C
J Immunol; 1996 Oct; 157(8):3420-9. PubMed ID: 8871640
[TBL] [Abstract][Full Text] [Related]
6. In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.
Bonyhadi M; Frohlich M; Rasmussen A; Ferrand C; Grosmaire L; Robinet E; Leis J; Maziarz RT; Tiberghien P; Berenson RJ
J Immunol; 2005 Feb; 174(4):2366-75. PubMed ID: 15699173
[TBL] [Abstract][Full Text] [Related]
7. Activation-induced apoptosis of mature T cells is dependent upon the level of surface TCR but not on the presence of the CD3 zeta ITAM.
She J; Matsui K; Terhorst C; Ju ST
Int Immunol; 1998 Nov; 10(11):1733-40. PubMed ID: 9846702
[TBL] [Abstract][Full Text] [Related]
8. An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells.
Knies D; Klobuch S; Xue SA; Birtel M; Echchannaoui H; Yildiz O; Omokoko T; Guillaume P; Romero P; Stauss H; Sahin U; Herr W; Theobald M; Thomas S; Voss RH
Oncotarget; 2016 Apr; 7(16):21199-221. PubMed ID: 27028870
[TBL] [Abstract][Full Text] [Related]
9. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
Skov S; Bregenholt S; Claesson MH
J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
[TBL] [Abstract][Full Text] [Related]
10. The TCR/CD3 complex in leukemogenesis and as a therapeutic target in T-cell acute lymphoblastic leukemia.
Dos Santos NR; Ghysdael J; Tran Quang C
Adv Biol Regul; 2019 Dec; 74():100638. PubMed ID: 31378701
[TBL] [Abstract][Full Text] [Related]
11. Introduction of T cell receptor (TCR)-alpha cDNA has differential effects on TCR-gamma delta/CD3 expression by PEER and Lyon-1 cells.
De Waal Malefyt R; Alarcon B; Yssel H; Sancho J; Miyajima A; Terhorst CP; Spits H; De Vries JE
J Immunol; 1989 May; 142(10):3634-42. PubMed ID: 2523930
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
[TBL] [Abstract][Full Text] [Related]
13. Variability of invariant mouse CD3epsilon chains detected by anti-CD3 antibodies.
Criado G; Feito MJ; Ojeda G; Sánchez A; Janeway CA; Portolés P; Rojo JM
Eur J Immunol; 2000 May; 30(5):1469-79. PubMed ID: 10820395
[TBL] [Abstract][Full Text] [Related]
14. Dual role of ERK5 in the regulation of T cell receptor expression at the T cell surface.
Rovira-Clavé X; Angulo-Ibáñez M; Tournier C; Reina M; Espel E
J Leukoc Biol; 2016 Jan; 99(1):143-52. PubMed ID: 26302753
[TBL] [Abstract][Full Text] [Related]
15. Basal and antigen-induced exposure of the proline-rich sequence in CD3ε.
de la Cruz J; Kruger T; Parks CA; Silge RL; van Oers NS; Luescher IF; Schrum AG; Gil D
J Immunol; 2011 Feb; 186(4):2282-90. PubMed ID: 21228347
[TBL] [Abstract][Full Text] [Related]
16. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
17. Role of CD3ε-mediated signaling in T-cell development and function.
Dave VP
Crit Rev Immunol; 2011; 31(1):73-84. PubMed ID: 21395513
[TBL] [Abstract][Full Text] [Related]
18. A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies.
Viola A; Linkert S; Lanzavecchia A
Eur J Immunol; 1997 Nov; 27(11):3080-3. PubMed ID: 9394839
[TBL] [Abstract][Full Text] [Related]
19. TCR/CD3 coupling to Fas-based cytotoxicity.
Vignaux F; Vivier E; Malissen B; Depraetere V; Nagata S; Golstein P
J Exp Med; 1995 Feb; 181(2):781-6. PubMed ID: 7530763
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil enhances apoptosis sensitivity of T lymphocytes mediated by CD3 epsilon.
Cheng H; Liu Y; Liu S; Zheng D
Cell Biochem Funct; 2004; 22(3):187-95. PubMed ID: 15124184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
